LINACS

Drug Index Methods Publications News About

Home › Monoclonal Antibodies (mAbs) › EGFR-Targeting

Drug Class

EGFR-Targeting

Cetuximab Necitumumab

Panitumumab

LINACS · Living systematic review on the safety of SBRT combined with systemic therapies
EORTC-ESTRO · OligoCare · PROSPERO CRD42024559453